- Case report
- Open Access
- Open Peer Review
Surgical treatment for thoracoabdominal intra-aortic thrombus with multiple infarctions: a case report
© The Author(s). 2016
- Received: 23 December 2015
- Accepted: 28 July 2016
- Published: 10 August 2016
Mobile intra-aortic thrombus without atherosclerosis, aneurysm, or congenital coagulopathy is very rare, and there are few reports especially in young or middle-aged patients. Furthermore, there are presently no established guidelines or common strategies for the treatment of mobile intra-aortic thrombus.
In this case report, we describe the first case of intra-aortic thrombus caused by secondary erythrocytosis and describe the recommended treatment strategy for intra-aortic thrombus.
We report a case of an independent 40-year-old Asian man with a current history of heavy cigarette smoking who had sudden onset of abdominal and lumbar pain. Contrast-enhanced computed tomography revealed partial renal and splenic infarction, and he was transferred to our hospital. He also had a large mural thrombus in his thoracoabdominal aorta. Blood analysis on admission showed a hemoglobin level of 19.4 g/dL and hematocrit of 54.3 %; his international normalized ratio of prothrombin time, fibrin degradation products, and activated partial thromboplastin time levels were 1.02, 2.8 μg/ml, and 26.9 seconds respectively. We could find no abnormalities in protein C and protein S activity levels. Lupus anticoagulant and anti-cardiolipin antibody were both negative. He had no past medical history of arrhythmia and we found no signs of an arrhythmic event during admission.
We promptly started anticoagulant therapy, but as the thrombus seemed at high risk of causing further critical infarction, we performed emergency aortic thrombectomy using partial extracorporeal circulation. To prevent dissemination of the thrombus during extracorporeal circulation, we first clamped his proximal and distal aorta on either side of the thrombus just before initiating extracorporeal circulation.
After the aortotomy we removed a 14-cm length of intra-aortic thrombus without residual lesion. He was discharged from our hospital 20 days after surgery. From the results of his blood analysis, we considered the only cause of this thrombus was secondary erythrocytosis, which was probably induced by his current heavy cigarette smoking.
We are the first to report such a thrombosis caused by secondary erythrocytosis and conclude that once the diagnosis of intra-aortic thrombus with systemic embolism is clear, emergency surgical removal of such a thrombus must be considered to prevent further embolic complications.
- Intra-aortic thrombus
- Surgical thrombectomy
Mobile intra-aortic thrombus is very rare but sometimes occurs mainly due to thrombi in the left side of the heart . Furthermore, there are few reports of mobile intra-aortic thrombus without atherosclerosis, aneurysm, or congenital coagulopathy, particularly in young or middle-aged patients .
We report a case of a middle-aged Asian man who complained of abdominal and lumbar pain. Contrast-enhanced computed tomography (CECT) revealed a mobile thrombus in his thoracoabdominal aorta with acute renal and splenic embolism. We performed emergency surgical thrombectomy and he was discharged from hospital with no complications.
We considered that the only major cause of this thrombus was secondary erythrocytosis that was probably induced by the patient’s current heavy tobacco smoking. We could not find any similar published articles describing the same cause of a thrombus.
A 40-year-old Asian man was hospitalized in our emergency department because of sudden abdominal and lumbar pain that woke him while sleeping. He had a medical history of hypertension but was not being treated with medications. He also had a current cigarette smoking history of 40 cigarettes per day for 20 years, and had no other related familial history. A physical examination showed left upper quadrant abdominal tenderness and bilateral costovertebral angle tenderness. No cardiac murmur or abnormal respiratory sounds were heard on auscultation. His blood pressure was 215/118 mmHg, heart rate was regular at 73 beats per minute, respiratory rate was 12 breaths per minute, and his body temperature was 36.8 °C.
A serial hematologic workup showed an extremely high hemoglobin level (19.4 g/dl) and hematocrit (54.3 %), but his white blood cell count and platelet count were within normal limits. No abnormal values of blood urea nitrogen, creatinine level, and hemostasis system function were found in this workup. His international normalized ratio of prothrombin time (PT-INR), fibrin degradation products (FDP), and activated partial thromboplastin time (APTT) levels were 1.02, 2.8 μg/ml, 26.9 seconds respectively. Only the level of his D-dimer was slightly increased (2.7 μg/ml).
After his admission to our emergency department, we immediately started systemic heparinization. But as we were concerned about the extremely high possibility that the thrombus could cause a further fatal systemic embolism, emergency surgical thrombectomy was performed on the same day.
The operation was started with our patient in a right half-lateral position, and preparations for femoral arteriovenous extracorporeal circulation were completed. A thoracoabdominal spiral incision was performed, and his aorta was approached at the level of the sixth intercostal via a retroperitoneal route. Epiaortic ultrasonography was performed prior to taping to detect the exact lesion of the thrombus, and we taped to aorta at the level of the fifth thoracic vertebra and just superior to the level of his renal artery. After his celiac, superior mesenteric, and left renal arteries were individually taped, his temperature was controlled to a mild hypothermia of 33 °C.
After the thrombectomy, his aorta could be sutured directly. He was discharged from our hospital 20 days after the surgery without any complications. He had no past medical history of atrial or ventricular arrhythmia and we found no signs of a paroxysmal arrhythmic event during admission.
Presently, he is still undergoing antiplatelet therapy and warfarin administration. Since he quit cigarette smoking, he has had no findings of polycythemia.
Most arterial embolisms occur due to thrombi in the left side of the heart , and only a few reports describe systemic embolism without vascular disease such as aortic dissection, aneurysm, atrial fibrillation, congenital coagulopathy, or intracardiac shunt. We only found published cases in which systemic arterial embolism occurred secondary to systemic sclerosis, malignant tumor, or protein C and protein S abnormalities [2, 3].
If intra-aortic thrombus is detected in a young patient, we have to consider and rule out congenital coagulopathy . However, some reports have noted that some of these coagulopathy disorders are not detected by current multisystemic hemostatic testing methods [4, 5]. We found no abnormal hemostatic data or familial history in our patient that would cause us to suspect a hemostatic disorder, and only polycythemia secondary to his heavy cigarette smoking was considered the cause of this thrombus. Recently, tobacco smoking has been considered to be significantly related to the risk of not only venous thrombus formation but also polycythemia, platelet dysfunction, and the formation of aortic thrombus [6, 7]. Our patient also had a current history of heavy cigarette smoking and thus was at possible risk of intra-aortic thrombus formation.
For the diagnosis and assessment of intra-aortic thrombus mobility, the recommended examinations are CECT or transesophageal echocardiography (TEE) [8–10]. We performed TEE intraoperatively in our patient and confirmed the mobility of the thrombus. The probability of a thrombus that has already caused systemic embolism to cause further embolism is reported to be approximately 73 % , but definitive therapeutic guidelines have not been established. For now, surgical thrombectomy, endovascular therapy including the use of stents, and medical treatment with heparin or tissue plasminogen activator have been reported [1–3]. However, thrombolysis with thrombolytic agents carries the risk of selectively disseminating thrombi released into the blood stream from the stalk of the lesion. Furthermore, there is no consensus on the dose or duration of the use of thrombolytic agents or on the definitive timing of stopping thrombolysis [12–14]. We could find no reports recommending thrombolytic medication for intra-aortic thrombus that has caused systemic arterial embolism.
Recently, as remarkable endovascular devices such as stent grafts or touching balloons have been developed, some case reports have described the successful treatment of intra-aortic thrombus by endovascular therapy . However, endovascular procedures for treating mobile thrombus obviously carry a high risk of iatrogenic systemic embolism , and as the long-term results of these devices remain to be confirmed, their appropriate adaptation for young patients such as ours is not clear .
If surgical thrombectomy is considered, we have to think about the risk of disseminating the remaining thrombus in the aorta at the start of extracorporeal circulation or during thrombectomy. Further, if the intimal aspect is not clear to permit direct suturing, the surgery must be extended to rebuild the aorta with a synthetic graft. However, the risk of thrombus dissemination at the start of extracorporeal circulation can be resolved by appropriate timing of the aortic clamping procedure and starting extracorporeal perfusion as described in this case.
Thrombectomy is reported to be easily completed in young patients with no arteriosclerotic vascular lesions, as in this case, and the risk of complications such as further systemic embolism or conversion to extended surgery is possibly quite less compared to that with thrombolytic medication therapy [1, 8]. Thus, surgical thrombectomy as a therapeutic strategy for intra-aortic thrombus with systemic aortic embolism has been recommended in several previous case reports [1–3, 8, 17].
The prevention of recurrence depends on the cause of the thrombus formation, and definitive evidence has not been established for either anticoagulant therapy or antiplatelet therapy . However, one study reported the possibility of anticoagulant therapy offering a preventive effect , and our patient continues on both anticoagulant and antiplatelet therapies. To date, he has experienced no recurrent thrombosis.
From the results of blood analysis of our patient, the only cause of his intra-aortic thrombus that we considered was secondary erythrocytosis that was probably induced by his current heavy cigarette smoking. We conclude that once a diagnosis of intra-aortic thrombus with systemic embolism is clear, emergency surgical removal must be considered to prevent further embolic complications.
APTT, activated partial thromboplastin time; CECT, contrast-enhanced computed tomography; FDP, fibrin degradation products; PT-INR, international normalized ratio of prothrombin time; TEE, transesophageal echocardiography
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. No assistance was utilized in the writing of this manuscript.
The authors declare that they have no funding sources with regard to this manuscript.
Availability of data and materials
Medical imaging data will not be shared because it is not fully anonymous.
KU, DK, and MH performed the operation. KU, DK, MH, TY, TT, NS, YM, and TS determined the treatment plan. KU and MH also performed patient follow-up. KU organized the writing of the manuscript and wrote the draft, and MH revised this manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Witten informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Kalangos A, Baldovinos A, Vuille C, Montessuit M, Faidutti B. Floating thrombus in ascending aorta: a rare cause of peripheral emboli. J Vasc Surg. 1997;26:150–4.View ArticlePubMedGoogle Scholar
- Soleimani A, Marzban M, Sahebjam M, Shirani S, Sotoudeh-Anvari M, Abbasi A. Floating thrombus in the aortic arch as an origin of simultaneous peripheral emboli. J Card Surg. 2008;23:762–4.PubMedGoogle Scholar
- Choi JB, Choi SH, Kim NH, Jeong JW. Floating thrombus in the peripheral aortic arch. Tex Heart Inst J. 2004;31:432–4.PubMedPubMed CentralGoogle Scholar
- Towne JB. Hypercoagulable states and unexplained vascular thrombosis. 3rd ed. St. Louis: Quality Medical Publishing; 1991. p. 101–18.Google Scholar
- Wiman B. The role of the fibrinolytic system in thrombotic disease. Acta Med Scand Suppl. 1987;715:169–71.PubMedGoogle Scholar
- Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and productivity losses – United States, 1997–2001. MMWR Morb Mortal Wkly Rep. 2005;54:625–8.Google Scholar
- Matetzky S, Tani S, Kangavari S, Dimayuga P, Yano J, Xu H, et al. Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity. Circulation. 2000;102:602–4.View ArticlePubMedGoogle Scholar
- Hanson JA, Lloyd ME, Hughes GR. Aortic root thrombus causing stroke in patient with lupus erythematosus. Scand J Rheumatol. 1994;23:156–8.View ArticlePubMedGoogle Scholar
- Sadony V, Walz M, Löhr E, Rimpel J, Richter HJ. Unusual cause of recurrent arterial embolism: floating thrombus in the aortic arch surgically removed under hypothermic cardiocirculatory arrest. Eur J Cardiothorac Surg. 1988;2:469–71.View ArticlePubMedGoogle Scholar
- Baumgartner J, Leupi F. Thrombosis of the ascending aorta – a rare cause for recurrent arterial embolism [in German]. Helv Chir Acta. 1993;60:163–6.PubMedGoogle Scholar
- Karalis DG, Chandrasekaran K, Victor MF, Ross Jr JJ, Mintz GS. Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol. 1991;17:73–8.View ArticlePubMedGoogle Scholar
- Moldveen-Geronimus M, Merriam Jr JC. Cholesterol embolization. From pathologic curiosity to clinical entity. Circulation. 1967;35:946–53.View ArticlePubMedGoogle Scholar
- Ridker PM, Michel T. Streptokinase therapy in cholesterol embolization. Am J Med. 1989;87:357–8.View ArticlePubMedGoogle Scholar
- Goebel N, Maire R, Streuli R. Flottierende Thromben in der Aorta ascendens. Vasa. 1983;12:397–9.PubMedGoogle Scholar
- Giovanni N, Daniela M, Giovanni M, Maria Teresa O, Silvia S, Davide F, et al. Endovascular treatment of aortic floating thrombus in patients presenting with acute lower limb ischemia. Int J Vasc Med. 2011;2011:604362.PubMedPubMed CentralGoogle Scholar
- Verhoye JP, de Latour B, Heautot JF, Vola M, Langanay T, Corbineau H, et al. Mid-term results of endovascular treatment for descending thoracic aorta diseases in high-surgical risk patients. Ann Vasc Surg. 2006;20:714–22.View ArticlePubMedGoogle Scholar
- Lee S, Cho JW, Kwon OC. Floating thrombus in the ascending aorta of the patient with systemic sclerosis – a case report. Korean J Thorac Cardiovasc Surg. 2011;44:72–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Bojar RM, Payne DD, Murphy RE, Schwartz SL, Belden JR, Caplan LR, et al. Surgical treatment of systemic atheroembolism from the thoracic aorta. Ann Thorac Surg. 1996;61:1389–93.View ArticlePubMedGoogle Scholar
- Bowdish ME, Weaver FA, Liebman HA, Rowe VL, Hood DB. Anticoagulation is an effective treatment for aortic mural thrombi. J Vasc Surg. 2002;36:713–9.View ArticlePubMedGoogle Scholar